Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7WJV

Crystal structure of human liver FBPase complexed with an covalent inhibitor

Summary for 7WJV
Entry DOI10.2210/pdb7wjv/pdb
DescriptorFructose-1,6-bisphosphatase 1, ADENOSINE MONOPHOSPHATE, 1,2-BENZISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE, ... (7 entities in total)
Functional Keywordsclassification: hydrolase organism(s): homo sapiens expression system: escherichia coli bl21(de3) inhibitor: covalent binding c128, cytosolic protein
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight154875.51
Authors
Cao, H.,Huang, Y.,Ren, Y.,Wan, J. (deposition date: 2022-01-08, release date: 2022-07-13, Last modification date: 2024-10-23)
Primary citationWen, W.,Cao, H.,Xu, Y.,Ren, Y.,Rao, L.,Shao, X.,Chen, H.,Wu, L.,Liu, J.,Su, C.,Peng, C.,Huang, Y.,Wan, J.
N -Acylamino Saccharin as an Emerging Cysteine-Directed Covalent Warhead and Its Application in the Identification of Novel FBPase Inhibitors toward Glucose Reduction.
J.Med.Chem., 65:9126-9143, 2022
Cited by
PubMed Abstract: With a resurgence of covalent drugs, there is an urgent need for the identification of new moieties capable of cysteine bond formation. Herein, we report on the -acylamino saccharin moieties capable of novel covalent reactions with cysteine. Their utility as alternative electrophilic warheads was demonstrated through the covalent modification of fructose-1,6-bisphosphatase (FBPase), a promising target associated with cancer and type 2 diabetes. The cocrystal structure of title compound bound with FBPase unexpectedly revealed that the -acylamino saccharin moiety worked as an electrophile warhead that covalently modified the noncatalytic C128 site in FBPase while releasing saccharin, suggesting a previously undiscovered covalent reaction mechanism of saccharin derivatives with cysteine. Treatment of title compound displayed potent inhibition of glucose production in vitro and in vivo. This newly discovered reactive warhead supplements the current repertoire of cysteine covalent modifiers while avoiding some of the limitations generally associated with established moieties.
PubMed: 35786925
DOI: 10.1021/acs.jmedchem.2c00336
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.724 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon